These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34957237)

  • 21. Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials.
    Verma S; Eikelboom JW; Nidorf SM; Al-Omran M; Gupta N; Teoh H; Friedrich JO
    BMC Cardiovasc Disord; 2015 Aug; 15():96. PubMed ID: 26318871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine for the prevention of ischemic stroke: An updated meta-analysis of randomized clinical trials.
    Al-Atta A; Kuzemczak M; Alkhalil M
    Brain Circ; 2021; 7(3):187-193. PubMed ID: 34667902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis.
    Xiang Z; Yang J; Yang J; Zhang J; Fan Z; Yang C; Di L; Ma C; Wu J; Huang Y
    Intern Emerg Med; 2021 Mar; 16(2):487-496. PubMed ID: 33400158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Samuel M; Tardif JC; Bouabdallaoui N; Khairy P; Dubé MP; Blondeau L; Guertin MC
    Can J Cardiol; 2021 May; 37(5):776-785. PubMed ID: 33075455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Updated Meta-Analysis of RCTs of Colchicine for Stroke Prevention in Patients with Coronary Artery Disease.
    Katsanos AH; Palaiodimou L; Price C; Themistocleous M; Lemmens R; Michopoulos I; Georgakis MK; Weimar C; Kelly P; Tsivgoulis G
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials.
    Andreis A; Imazio M; Avondo S; Casula M; Paneva E; Piroli F; De Ferrari GM
    J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):637-644. PubMed ID: 33399344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
    Aimo A; Pascual Figal DA; Bayes-Genis A; Emdin M; Georgiopoulos G
    Eur J Clin Invest; 2021 Apr; 51(4):e13464. PubMed ID: 33251579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial.
    Mohammadnia N; Los J; Opstal TSJ; Fiolet ATL; Eikelboom JW; Mosterd A; Nidorf SM; Budgeon CA; Tijssen JGP; Thompson PL; Tack CJ; Simsek S; Bax WA; Cornel JH; El Messaoudi S
    Front Cardiovasc Med; 2023; 10():1244529. PubMed ID: 37868776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis.
    Nogic J; Mehta O; Tong D; Brown AJ; Layland J
    Cardiol Ther; 2023 Mar; 12(1):171-181. PubMed ID: 36609745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M
    J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials.
    Wang W; Liu J; Fang J; Liu Y; An T; Zou M; Cheng G
    Int J Cardiol; 2017 May; 235():73-86. PubMed ID: 28284499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    Tardif JC; Kouz S; Waters DD; Bertrand OF; Diaz R; Maggioni AP; Pinto FJ; Ibrahim R; Gamra H; Kiwan GS; Berry C; López-Sendón J; Ostadal P; Koenig W; Angoulvant D; Grégoire JC; Lavoie MA; Dubé MP; Rhainds D; Provencher M; Blondeau L; Orfanos A; L'Allier PL; Guertin MC; Roubille F
    N Engl J Med; 2019 Dec; 381(26):2497-2505. PubMed ID: 31733140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
    Garcia S; Sandoval Y; Roukoz H; Adabag S; Canoniero M; Yannopoulos D; Brilakis ES
    J Am Coll Cardiol; 2013 Oct; 62(16):1421-31. PubMed ID: 23747787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Shrestha DB; Budhathoki P; Sedhai Y; Khadka M; Pokharel S; Yadav S; Patel T; Elgendy I; Mir WAY; Patel NK
    J Cardiovasc Pharmacol; 2022 Apr; 79(4):420-430. PubMed ID: 34935703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: A systematic review and meta-analysis.
    Tien YY; Huang HK; Shih MC; Tu YK
    J Cardiol; 2021 Jun; 77(6):576-582. PubMed ID: 33272780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.
    Wang H; Jiang M; Li X; Zhao Y; Shao J; Liu Z; Lin L; Xu Q; Wang L; Lu X; Zhang H; Chen Y; Zhang R
    Front Cardiovasc Med; 2021; 8():726341. PubMed ID: 34513960
    [No Abstract]   [Full Text] [Related]  

  • 38. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting stents or coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of four randomized trials and seventeen observational studies.
    Li Q; Zhang Z; Yin RX
    Trials; 2013 May; 14():133. PubMed ID: 23782856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.
    Zimarino M; Ricci F; Romanello M; Di Nicola M; Corazzini A; De Caterina R
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):3-12. PubMed ID: 25846673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.